SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Skye
Lv6
2
1930 积分
2023-11-16 加入
最近求助
最近应助
互助留言
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
1个月前
已完结
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice
1个月前
已完结
Characteristics of breast cancer in Central China, literature review and comparison with USA
1个月前
已完结
Breast cancer in China
1个月前
已完结
The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening
1个月前
已完结
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
1个月前
已完结
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer
2个月前
已完结
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy
2个月前
已完结
Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches
3个月前
已完结
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer
3个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了
2个月前
感谢,点赞,速度真快,帮大忙了
2个月前
感谢,点赞,速度真快,帮大忙了
3个月前
感谢,点赞,速度真快,帮大忙了
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论